Unknown PHASE4 INTERVENTIONAL 2-arm NCT00567957

Remifentanil for General Anesthesia in Preeclamptics

Remifentanil for c-Section With General Anesthesia in Severe Preeclamptic Patients

Sponsor: Istanbul University

Conditions Hypertension, Pregnancy-Induced Pre-Eclampsia Pregnancy Complications

Updated 5 times since 2017 Last updated: Dec 4, 2007 Started: Feb 29, 2008 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypertension, Pregnancy-Induced and Pre-Eclampsia and is currently ongoing. Istanbul University leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istanbul University

Data source: Istanbul University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)